Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY)

Historical Holders from Q3 2020 to Q3 2025

Symbol
HRMY on Nasdaq
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
57,417,494
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
47,298,452
Holdings value
$1,303,507,421
% of all portfolios
0.009%
Number of holders
289
Number of buys
154
Number of sells
-114
Average buys %
+0%
Average sells %
-0.03%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Marshman Fund Trust II 10.6% $178,084,462 6,051,120 Marshman Fund Trust II 31 Dec 2024
BlackRock, Inc. 10.1% -17.5% $169,781,023 -$35,290,072 5,768,978 -17.2% BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 8.3% $139,310,113 4,733,609 The Vanguard Group 31 Dec 2024
FMR LLC 6.7% $106,022,551 3,846,972 FMR LLC 30 Sep 2025

Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 47,298,452 $1,303,507,421 -$114,855,219 $27.56 289
2025 Q2 51,269,247 $1,620,478,469 +$22,306,889 $31.6 276
2025 Q1 50,193,424 $1,664,235,088 -$100,697,267 $33.19 267
2024 Q4 52,708,406 $1,813,638,877 +$62,320,767 $34.41 244
2024 Q3 50,136,635 $2,005,018,440 +$11,121,046 $40 231
2024 Q2 50,163,988 $1,513,604,428 +$34,652,893 $30.17 218
2024 Q1 48,982,561 $1,644,752,000 +$41,053,934 $33.58 206
2023 Q4 47,832,583 $1,544,993,160 -$51,074,763 $32.3 219
2023 Q3 49,527,453 $1,623,105,557 -$85,461,798 $32.77 203
2023 Q2 51,951,129 $1,828,229,880 +$28,751,282 $35.19 207
2023 Q1 51,270,566 $1,674,006,219 -$29,571,258 $32.65 213
2022 Q4 51,015,535 $2,810,596,096 +$34,893,529 $55.1 238
2022 Q3 50,461,165 $2,237,024,113 +$91,703,030 $44.29 195
2022 Q2 47,874,920 $2,335,182,718 +$99,684,851 $48.77 173
2022 Q1 45,933,803 $2,235,023,234 +$79,981,090 $48.65 168
2021 Q4 44,541,354 $1,899,444,678 +$107,131,256 $42.64 138
2021 Q3 30,932,269 $1,185,850,908 +$116,456,188 $38.33 99
2021 Q2 27,994,218 $790,282,400 -$7,611,822 $28.23 79
2021 Q1 27,468,517 $907,561,000 -$18,485,709 $33.04 55
2020 Q4 27,956,363 $998,030,405 -$18,654,367 $36.15 59
2020 Q3 28,549,056 $940,508,000 +$940,508,000 $33.9 44